Puzzled by the recent FDA decisions? Dr. Sanjay Kaul discusses the regulatory environment for diabetes and obesity medications.

Dan Hurley gives a passionate assessment of the rise of diabetes in his book, Diabetes Rising .

The Obesity Society's annual meeting has long been our favorite place to catch up on the basic science research behind this critical problem.

In October, Novo Nordisk announced that it had submitted its two new “next-generation” insulin products for approval in both the US and Europe (and Japan to follow soon...

Eye diseases leading to blindness are consistently ranked among the greatest fears of people with diabetes, and the most common of these eye diseases is called diabetic...

On January 27, the Food and Drug Administration (FDA) granted approval to Bydureon, a new drug for type 2 diabetes that is injected once a week. Approved last year in...

In late November, the Centers for Medicare and Medicaid Services (the federal agency that administers the two public insurance programs) announced that Medicare would...

diaTribe 's take on the recent New England Journal of Medicine's piece on weight gain - and loss!

We had the privilege of attending the inaugural Partnership for a Healthier America (PHA) Building a Healthier Future Summit in late 2011 in Washington, DC, where we...

Want faster acting insulin? CDE Gary Scheiner shows you some options with five innovative tips that you may want to consider…

The Diabetes Barometer

We love articles with information that you can apply to your own life. In this article, you receive guidance on how to lower your risk of cardiovascular disease, the...

A new book on diabetes gives patients a nice framework for their care.

On November 29, NeuroMetrix announced that it had cleared the final hurdle holding up the introduction of the Sensus Pain Management System, designed for the treatment...

The Centers for Disease Control and Prevention (CDC) recently released a report tracking the skyrocketing prevalence of diabetes throughout all fifty states, the...

diaTribe salutes director Jennifer Mackenzie for her emerging film Sugar Babies . The documentary examines the impact of type 1 and type 2 diabetes on children in...

The New England Journal of Medicine just published the results of a poll (1,290 votes from 75 countries) that asked readers to vote on the government regulation (e.g.,...

Exercise and weight loss have been shown to significantly reduce a person’s risk of moving from prediabetes to type 2 diabetes. However, insurance coverage for these...

What’s an SGLT-2 inhibitor and how does it work? Includes cool FAQ!

On August 29, J&J’s chronic pain drug Nucynta ER (tapentadol) was granted FDA approval for the management of the pain associated with diabetic peripheral neuropathy...